The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance
![Pathogens | Free Full-Text | An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease | HTML Pathogens | Free Full-Text | An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease | HTML](https://www.mdpi.com/pathogens/pathogens-10-01381/article_deploy/html/images/pathogens-10-01381-g001.png)
Pathogens | Free Full-Text | An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease | HTML
![Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology](https://www.futuremedicine.com/cms/10.2217/fvl-2018-0166/asset/images/medium/figure1.gif)